Literature DB >> 233103

Postradiation renovascular hypertension.

C W McGill, T M Holder, T H Smith, K W Ashcraft.   

Abstract

Radiation injury to arteries can represent a significant complication of therapeutic irradiation, even when the dosage used has not been excessive as judged by approved protocols. Children in whom therapeutic abdominal irradiation has been used should be monitored indefinitely for the development of hypertension. The presence of hypertension in such children with normal blood urea nitrogen (BUN) and creatinine, and without proteinuria, should prompt investigation for a renovascular lesion. Standard bypass procedures are usually effective, although the long-term success may be compromised by continuing changes in affected vessels.

Entities:  

Mesh:

Year:  1979        PMID: 233103     DOI: 10.1016/s0022-3468(79)80275-4

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study.

Authors:  Daniel M Green; Mingjuan Wang; Matthew J Krasin; Andrew M Davidoff; DeoKumar Srivastava; Dennis W Jay; Kirsten K Ness; Barry L Shulkin; Sheri L Spunt; Deborah P Jones; Jennifer Q Lanctot; Kyla C Shelton; Rachel C Brennan; Daniel A Mulrooney; Matthew J Ehrhardt; Todd M Gibson; Beth A Kurt; Leslie L Robison; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2020-07-24       Impact factor: 3.167

2.  Radiation-induced renovascular hypertension successfully treated with transluminal angioplasty: case report.

Authors:  J Milutinovic; M Darcy; K A Thompson
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Feb-Mar       Impact factor: 2.740

3.  Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma.

Authors:  M Bernstein; M Lumley; G Davidson; N Laperriere; P Leung
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.